Works by Sampol, Antonia


Results: 47
    1
    2
    3

    Analysis of Personality Traits in Patients with Hodgkin Lymphoma.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 8, p. 1631, doi. 10.3390/jcm10081631
    By:
    • Roso-Bas, Fatima;
    • Alonso-Llobregat, Maria Dolores;
    • Bento, Leyre;
    • Sanchez-Gonzalez, Blanca;
    • Herraez, Ines;
    • Garcia-Dilla, Pilar;
    • Vallespir, Catalina;
    • Rado, Francesca;
    • Rodriguez, Raquel;
    • Garcia-Pallarols, Francesc;
    • Aguirre, Irache;
    • Bargay, Joan;
    • Sampol, Antonia;
    • Salar, Antonio;
    • Gutierrez, Antonio
    Publication type:
    Article
    4
    5
    6
    7

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    8

    Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
    By:
    • Oñate, Guadalupe;
    • Pratcorona, Marta;
    • Garrido, Ana;
    • Artigas-Baleri, Alicia;
    • Bataller, Alex;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susana;
    • Coll, Rosa;
    • Salamero, Olga;
    • Vall-Llovera, Ferran;
    • Sampol, Antònia;
    • Garcia, Antoni;
    • Cervera, Marta;
    • Avila, Sara Garcia;
    • Bargay, Joan;
    • Ortín, Xavier;
    • Nomdedéu, Josep F.;
    • Esteve, Jordi;
    • Sierra, Jorge
    Publication type:
    Article
    9
    10

    Biological relapse in multiple myeloma: Outcome and treatment strategies in a Spanish real‐world setting.

    Published in:
    HemaSphere, 2024, v. 8, n. 7, p. 1, doi. 10.1002/hem3.81
    By:
    • Alegre, Adrián;
    • Gironella, Mercedes;
    • Escalante, Fernando;
    • Bergua, Juan M.;
    • Martínez‐Chamorro, Carmen;
    • López, Aurelio;
    • González, Esther;
    • Bárez, Abelardo;
    • Somolinos, Nieves;
    • Persona, Ernesto P.;
    • Cabrera, Alexia S.;
    • Soler, Alfons;
    • Rodríguez, Belén I.;
    • López, Joaquín M.;
    • González, Yolanda;
    • Giménez, Verónica C.;
    • Sampol, Antonia;
    • Muñoz, Carolina;
    • Vilanova, David;
    • Durán, Marta
    Publication type:
    Article
    11

    P531: MIDOSTAURIN PLUS 7 + 3 OR QUIZARTINIB PLUS 7 + 3 IN FLT3‐ITD MUTATED AML.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969032.40255.74
    By:
    • Tormo, Mar;
    • Diaz‐Beya, Marina;
    • Beneit, Paola;
    • Fernández Moreno, Ainhoa;
    • Arnan, Montserrat;
    • Garrido Diaz, Ana;
    • Vives, Susana;
    • García Fortes, Maria;
    • Sampol, Antonia;
    • Labrador, Jorge;
    • Garcia‐Guiñon, Antonio;
    • Botella, Carmen;
    • Miguel Bergua Burgues, Juan;
    • Olave, Mayte;
    • Luz Amigo, Maria;
    • Ortín, Xavier;
    • Ferran Vall‐Llovera, Ferrand;
    • Pereiro, Maria;
    • Serrano, Josefina;
    • Jose Sayas Lloris, Maria
    Publication type:
    Article
    12

    S132: UPDATED RESULTS OF VEN-A-QUI STUDY: A PHASE 1-2 TRIAL TO ASSESS THE SAFETY AND EFFICACY OF TRIPLETS FOR NEWLY DIAGNOSED UNFIT AML PATIENTS: AZACITIDINE OR LOW-DOSE CYTARABINE WITH VENETOCLAX AND QUIZARTINIB.

    Published in:
    2023
    By:
    • Miguel Bergua Burgues, Juan;
    • Rodríguez-Veiga, Rebeca;
    • Cano Ferri, Isabel;
    • Vall-Llovera Calmet, Ferran;
    • Garcia-Guiñon, Antonio;
    • Gomez Espuch, Joaquin;
    • Colorado, Mercedes;
    • Casas-Avilés, Ignacio;
    • Esteve, Jordi;
    • Sampol, Antonia;
    • Victoria Verdugo, Maria;
    • Ramos, Fernando;
    • Valero, Marta;
    • Gloria Acuña Cruz, Evelyn;
    • Boluda, Blanca;
    • Torres Miñana, Laura;
    • Martinez-Lopez, Joaquín;
    • Barragan, Eva;
    • Ayala Diaz, Rosa;
    • Martinez-Cuadrón, David
    Publication type:
    Abstract
    13
    14

    Assessment of the psychometric properties of the Spanish version of EORTC QLQ-MY20 and evaluation of health-related quality of Life outcomes in patients with relapsed and/or refractory multiple myeloma in the real-world setting in Spain: results from the CharisMMa study

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 11, p. 1847, doi. 10.1080/10428194.2023.2240922
    By:
    • Dachs, Laura Rosiñol;
    • Gaisán, Carmen Montes;
    • Bustamante, Gabriela;
    • López, Sebastián Garzón;
    • García, Esther González;
    • Persona, Ernesto Pérez;
    • González-Calle, Verónica;
    • Auzmendi, Maialen Sirvent;
    • Pérez, José Maria Arguiñano;
    • González Montes, Yolanda;
    • Ríos Tamayo, Rafael;
    • de Miguel Llorente, Dunia;
    • Bernal, Luis Palomera;
    • Mayol, Antonia Sampol;
    • Caro, Carmen Couto;
    • Grande, Marta;
    • Fernández-Nistal, Alonso;
    • Naves, Andrea;
    • Miguel, Enrique M. Ocio San
    Publication type:
    Article
    15

    Bone marrow VEGFC expression is associated with multilineage dysplasia and several prognostic markers in adult acute myeloid leukemia, but not with survival.

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 10, p. 2383, doi. 10.1080/10428194.2017.1422858
    By:
    • Guillem, Vicent;
    • Calabuig, Marisa;
    • Brunet, Salut;
    • Esteve, Jordi;
    • Escoda, Lourdes;
    • Gallardo, David;
    • Ribera, Josep-Maria;
    • Queipo de Llano, María Paz;
    • Arnan, Montserrat;
    • Pedro, Carme;
    • Amigo, María Luz;
    • Martí-Tutusaus, Josep M.;
    • García-Guiñón, Antoni;
    • Bargay, Joan;
    • Sampol, Antonia;
    • Salamero, Olga;
    • Font, Llorenç;
    • Talarn, Carme;
    • Hoyos, Montserrat;
    • Díaz-Beyá, Marina
    Publication type:
    Article
    16

    Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 3, p. 656, doi. 10.3109/10428194.2014.930849
    By:
    • Ferrà, Christelle;
    • Sanz, Jaime;
    • Díaz-Pérez, Miguel-Angel;
    • Morgades, Mireia;
    • Gayoso, Jorge;
    • Cabrera, José-Rafael;
    • Villaescusa, Teresa;
    • Sampol, María-Antonia;
    • Fernández-Avilés, Francesc;
    • Solano, Carlos;
    • Ortín, Miguel;
    • Duarte, Rafael;
    • Cuesta, Marian;
    • Heras, Inmaculada;
    • de la Serna, Javier;
    • Moraleda, José-María;
    • Barrenetxea, Cristina;
    • González-Vicent, Marta;
    • Sanz, Guillermo;
    • Ribera, Josep-Maria
    Publication type:
    Article
    17
    18

    Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen ( RIC) and post-allogeneic transplantation for high-risk myeloma patients.

    Published in:
    British Journal of Haematology, 2013, v. 162, n. 4, p. 474, doi. 10.1111/bjh.12410
    By:
    • Caballero‐Velázquez, Teresa;
    • López‐Corral, Lucia;
    • Encinas, Cristina;
    • Castilla‐Llorente, Cristina;
    • Martino, Rodrigo;
    • Rosiñol, Laura;
    • Sampol, Antonia;
    • Caballero, Dolores;
    • Serrano, David;
    • Heras, Inmaculada;
    • San Miguel, Jesús;
    • Pérez‐Simón, José A.
    Publication type:
    Article
    19

    Frequency and Distribution of KIR Genotypes of Donors‐Recipient Pairs in the Haploidentical Haematopoietic Stem Cell Transplantation Setting: Collaborative Study by the Spanish Working Group in Histocompatibility and Transplant Immunology (GETHIT) and the Spanish Haematopoietic Transplantation and Cell Therapy Group (GETH‐TC)

    Published in:
    HLA: Immune Response Genetics, 2025, v. 105, n. 5, p. 1, doi. 10.1111/tan.70248
    By:
    • Luis‐Hidalgo, Mar;
    • Planelles, Dolores;
    • Piñana, José Luis;
    • Carbonell, Juan;
    • Amat, Paula;
    • Gómez‐Seguí, Inés;
    • Guerreiro, Manuel;
    • Caballero, Abelardo;
    • Torío, Alberto;
    • Pascual‐Cascón, Mª. Jesús;
    • Boix, Francisco;
    • Marín Rubio, Luis;
    • Vázquez, Lourdes;
    • Martínez‐Pomar, Natalia;
    • Cunill, Vanesa;
    • Sampol, Antonia;
    • Ochoa, Julio;
    • Arbona, Cristina;
    • Solano, Carlos
    Publication type:
    Article
    20
    21
    22

    Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma.

    Published in:
    2021
    By:
    • Cejalvo, María José;
    • Bustamante, Gabriela;
    • González, Esther;
    • Vázquez-Álvarez, Judith;
    • García, Ricarda;
    • Ramírez-Payer, Ángel;
    • Pérez-Persona, Ernesto;
    • Abella, Eugenia;
    • Garzón, Sebastián;
    • García, Antoni;
    • Jarque, Isidro;
    • González, Marta Sonia;
    • Sampol, Antonia;
    • Motlló, Cristina;
    • Martí, Josep María;
    • Alcalá, Magdalena;
    • Duro, Rafael;
    • González, Yolanda;
    • Sastre, José Luis;
    • Sarrà, Josep
    Publication type:
    journal article
    23

    PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation.

    Published in:
    Annals of Hematology, 2018, v. 97, n. 11, p. 2217, doi. 10.1007/s00277-018-3438-y
    By:
    • Santos, Nazly;
    • Rodríguez-Romanos, Rocío;
    • De La Cámara, Rafael;
    • Brunet, Salut;
    • Nieto, Jose B.;
    • Buño, Ismael;
    • Martínez, Carmen;
    • Jiménez-Velasco, Antonio;
    • Vallejo, Carlos;
    • González, Marcos;
    • Solano, Carlos;
    • Ferrá, Christelle;
    • Sampol, Antonia;
    • Pérez-Simón, Jose A.;
    • López-Jiménez, Javier;
    • Díez, José L.;
    • Gallardo, David;
    • On Behalf Of The Gvhd/immunotherapy Working Party Of The Spanish Group Of Hematopoietic Transplant (geth);
    • Gvhd/immunotherapy Working Party Of The Spanish Group Of Hematopoietic Transplant (geth)
    Publication type:
    Article
    24

    Plasma from patients undergoing allogeneic hematopoietic stem cell transplantation promotes NETOSIS in vitro and correlates with inflammatory parameters and clinical severity.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1353106
    By:
    • López-Andrade, Bernardo;
    • Cunill, Vanesa;
    • Andreu, Valero;
    • Bento, Leyre;
    • Segura-Guerrero, Marina;
    • Moñino, Andrea;
    • Iglesias, Julio;
    • Julià, Maria Rosa;
    • Durán, Maria Antonia;
    • Ballester, Maria Carmen;
    • Muncunill, Josep;
    • Sampol, Antonia
    Publication type:
    Article
    25
    26
    27
    28
    29

    From Clinical Perception to Implicit Bias: Understanding Personality Traits in Lymphoma Patients.

    Published in:
    Cancers, 2025, v. 17, n. 11, p. 1743, doi. 10.3390/cancers17111743
    By:
    • Roso-Bas, Fátima;
    • Alonso-Llobregat, María Dolores;
    • Bento, Leyre;
    • Sánchez-González, Blanca;
    • Lebrahimi, Layla Aoukhiyad;
    • Balanzat, Inés Herráez;
    • García-Dilla, Pilar;
    • García-Pallarols, Francesc;
    • Gil, Sara Nistal;
    • Romero, Samuel;
    • Vidal, María-Jesús;
    • Bonis-Braun, Carolina De;
    • León, Yapci Ramos de;
    • Infante, María Stefania;
    • Domingo-Domenech, Eva;
    • Ramírez, Susana;
    • Bargay, Joan;
    • Sampol, Antonia;
    • Salar, Antonio;
    • Gutiérrez, Antonio
    Publication type:
    Article
    30

    Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.

    Published in:
    Cancers, 2023, v. 15, n. 11, p. 2964, doi. 10.3390/cancers15112964
    By:
    • de la Rubia, Javier;
    • Alonso, Rafael;
    • Clavero, María Esther;
    • Askari, Elham;
    • García, Alfonso;
    • Antón, Cristina;
    • Fernández, Margarita;
    • Escalante, Fernando;
    • García, Ana;
    • Rios-Tamayo, Rafael;
    • Conesa, Venancio;
    • Bermúdez, María Arancha;
    • Merchán, Beatriz;
    • Velasco, Alberto E.;
    • Blanchard, María Jesús;
    • Sampol, Antonia;
    • Gainza, Eukene;
    • Hernández, Prisma Montserrat;
    • Alegre, Adrián
    Publication type:
    Article
    31

    CD200 in acute myeloid leukemia: marked upregulation in CEBPA biallelic mutated cases.

    Published in:
    Diagnostic Pathology, 2025, v. 20, n. 1, p. 1, doi. 10.1186/s13000-025-01655-w
    By:
    • González-Guerrero, Laura;
    • Castellet, Helena;
    • Martínez, Clara;
    • González, Nuria;
    • Guijarro, Francesca;
    • Lloveras, Natalia;
    • Pratcorona, Marta;
    • Gich, Ignasi;
    • Berenguer-Molins, Pau;
    • Perera-Bel, Júlia;
    • Zamora, Lurdes;
    • Mascaró, Martí;
    • Sampol, Antonia;
    • Garcia-Guiñón, Antoni;
    • Vives, Susana;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Villamor, Neus;
    • Nomdedéu, Josep F.
    Publication type:
    Article
    32

    Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.

    Published in:
    British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
    By:
    • Bataller, Alex;
    • Oñate, Guadalupe;
    • Diaz‐Beyá, Marina;
    • Guijarro, Francesca;
    • Garrido, Ana;
    • Vives, Susana;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Salamero, Olga;
    • Sampol, Antònia;
    • Coll, Rosa;
    • Vall‐Llovera, Ferran;
    • Oliver‐Caldés, Aina;
    • López‐Guerra, Mònica;
    • Pratcorona, Marta;
    • Zamora, Lurdes;
    • Villamon, Eva;
    • Roué, Gaël;
    • Blanco, Adoración;
    • Nomdedeu, Josep F.
    Publication type:
    Article
    33

    The implication of 'unknown significance' variants in next‐generation sequencing in diagnosis and donor selection for allogenic haematopoietic stem cell transplantation. Report of a case of myelodysplastic syndrome with a polymorphism in the tyrosine kinase 2 (TYK2) gene

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 4, p. e182, doi. 10.1111/bjh.16590
    By:
    • López‐Andrade, Bernardo;
    • Bento, Leyre;
    • Diez Campelo, Maria;
    • López Cadenas, Félix;
    • González Martín, Teresa;
    • Lo Riso, Laura;
    • Novo, Andres;
    • Martinez‐Serra, Jorge;
    • Ballester, Carmen;
    • Sampol, Antonia;
    • Duran, Maria Antonia
    Publication type:
    Article
    34

    Phase II trial of ofatumumab plus ESHAP (O- ESHAP) as salvage treatment for patients with relapsed or refractory classical Hodgkin lymphoma after first-line chemotherapy.

    Published in:
    British Journal of Haematology, 2016, v. 174, n. 6, p. 859, doi. 10.1111/bjh.14133
    By:
    • Martínez, Carmen;
    • Díaz‐López, Antonio;
    • Rodriguez‐Calvillo, Mercedes;
    • García‐Sanz, Ramón;
    • Terol, María José;
    • Pérez‐Ceballos, Elena;
    • Jiménez, Maria J.;
    • Cantalapiedra, Alberto;
    • Domingo‐Domenech, Eva;
    • Rodriguez, María José;
    • Sampol, Antonia;
    • Espeso, Manuel;
    • López, Francisco‐Javier;
    • Briones, Javier;
    • García, Juan F.;
    • Sureda, Anna
    Publication type:
    Article
    35
    36
    37

    P-178: Impact of t(11;14) according to induction regimen in newly diagnosed transplant-eligible multiple myeloma patients: long term follow-up of GEM05MENOS65 and GEM2012 PETHEMA/GEM studies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S134, doi. 10.1016/S2152-2650(21)02305-3
    By:
    • Moreno, David;
    • Oriol, A.;
    • de la Rubia, Javier;
    • Hernández, Miguel Teodoro;
    • Iñigo, Belen;
    • Palomera, Luis;
    • de Arriba, Felipe;
    • González, Yolanda;
    • Teruel, Ana Isabel;
    • Granell, Miquel;
    • de la Guía, Ana López;
    • Mayol, Antonia Sampol;
    • Ríos, Rafael;
    • Sureda, A.;
    • Gutierrez, Norma C.;
    • Calasanz, María José;
    • Ramos, María Luisa Martin;
    • Mateos, María-Victoria;
    • San-Miguel, Jesús F.;
    • Lahuerta, Juan José
    Publication type:
    Article
    38

    P-021: Experience with autologous stem-cell transplant (auto-SCT) in patients with systemic light-chain amyloidosis (LA) at our center.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S51, doi. 10.1016/S2152-2650(21)02155-8
    By:
    • Carbonero, Javier Díaz;
    • Guerrero, Elena Medina;
    • Montaña, Albert Pérez;
    • García, Antonio Gutierrez;
    • Raga, Jose María Sánchez;
    • del Carmen Ballester Ruíz, María;
    • Moya, María Jiménez;
    • León, Sandra Pérez;
    • Rincón, Andrea Provencio;
    • de Miguel, Leyre Bento;
    • García, Andrés Novo;
    • Maño, Lucía García;
    • Mayol, Antonia Sampol
    Publication type:
    Article
    39

    Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.

    Published in:
    2021
    By:
    • Rodriguez-Otero, Paula;
    • Sirvent, Maialen;
    • González-Rodríguez, Ana Pilar;
    • Lavilla, Esperanza;
    • de Coca, Alfonso García;
    • Arguiñano, José María;
    • Martí, Josep M.;
    • Cabañas, Valentin;
    • Motlló, Cristina;
    • de Cabo, Erik;
    • Encinas, Cristina;
    • Murillo, Ilda;
    • Hernández-Rivas, Jose Ángel;
    • Pérez-Persona, Ernesto;
    • Casado, Felipe;
    • Sampol, Antonia;
    • García, Ricarda;
    • Blanchard, María Jesús;
    • Anguita, Magdalena;
    • Lafuente, Ana Paz
    Publication type:
    journal article
    40

    Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e289, doi. 10.1016/j.clml.2019.09.476
    By:
    • Rubia, Javier De La;
    • Pérez, Ariadna;
    • Rosinol, Laura;
    • Arnao, Mario;
    • Teruel, Ana Isabel;
    • Herrera, Inmaculada;
    • Albo, Carmen;
    • Vaz, Carlos;
    • Krisnk, Isabel;
    • Bermudez, Arancha;
    • Pascual, María J.;
    • Encinas, Cristina;
    • Cabanas, Valentín;
    • Jurado, Manuel;
    • Gonzalez, Sonia;
    • Viguria, Maria C.;
    • Chinea, Anabelle;
    • Ferra, Christelle;
    • Sampol, Antonia;
    • Solano, Carlos
    Publication type:
    Article
    41

    Prescription Patterns and Outcomes of First-Line Therapy for Non-Transplant Eligible Multiple Myeloma Real-Life Patients According to Age: A Retrospective Analysis of the 2012-2016 Period.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e237, doi. 10.1016/j.clml.2019.09.395
    By:
    • Cejalvo, María José;
    • Bustamante, Gabriela;
    • González, Esther;
    • Vázquea-Álvarez, Judith;
    • García, Ricarda;
    • Payer, Angel Ramirez;
    • Pérez-Persona, Ernesto;
    • Abella, Eugenia;
    • Lopez, Sebastian Garzon;
    • Guiñon, Antonio Garcia;
    • Jarque, Isidro;
    • Gonzalez, Marta S.;
    • Sampol, Antonia;
    • Motllo, Cristina;
    • Martí, Josep Maria;
    • Alcalá, Magdalena;
    • Duro, Rafael;
    • Gonzalez, Yolanda;
    • Sastre, Jose Luís;
    • Sarrá, Josep
    Publication type:
    Article
    42

    Prognostic Significance of Red Blood Cell Distribution Width (RDW) and Diverse Hemogram Ratios in Newly Diagnosed Multiple Myeloma (NDMM).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e178, doi. 10.1016/j.clml.2019.09.298
    By:
    • Jiménez-Julià, Sara Aida;
    • Montaña, Albert Pérez;
    • León, Sandra Pérez;
    • Andrade, Bernardo López;
    • Sánchez Raga, José María;
    • Esteve, Júlia Domíngez;
    • Vercher, Javier;
    • Villaverde, Sofía;
    • Farreny, Josep Muncunill;
    • Teresa, Ros Matheu;
    • Neus, Beltran Serra;
    • Lo Riso, Laura;
    • Duran Pastor, Maria Antonia;
    • Sampol, Antonia
    Publication type:
    Article
    43

    Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
    By:
    • Oñate, Guadalupe;
    • Garrido, Ana;
    • Arnan, Montserrat;
    • Pomares, Helena;
    • Alonso, Ester;
    • Tormo, Mar;
    • Diaz-Beya, Marina;
    • Vives, Susana;
    • Zamora, Lurdes;
    • Sampol, Antonia;
    • Coll, Rosa;
    • Salamero, Olga;
    • Cervera, Marta;
    • Garcia, Antoni;
    • Vall-Llovera, Ferran;
    • Garcia-Avila, Sara;
    • Bargay, Joan;
    • Ortin, Xavier;
    • Iranzo, Eva;
    • Guijarro, Francisca
    Publication type:
    Article
    44
    45

    LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors.

    Published in:
    Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1066393
    By:
    • Cruz, David;
    • Rodríguez-Romanos, Rocío;
    • González-Bartulos, Marta;
    • García-Cadenas, Irene;
    • de la Cámara, Rafael;
    • Heras, Inmaculada;
    • Buño, Ismael;
    • Santos, Nazly;
    • Lloveras, Natàlia;
    • Velarde, Pilar;
    • Tuset, Esperanza;
    • Martínez, Carmen;
    • González, Marcos;
    • Sanz, Guillermo F.;
    • Ferrá, Christelle;
    • Sampol, Antonia;
    • Coll, Rosa;
    • Pérez-Simón, Jose A.;
    • López-Jiménez, Javier;
    • Jurado, Manuel
    Publication type:
    Article
    46

    5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 755, doi. 10.1111/ejh.13862
    By:
    • Díaz‐Santa, Johana;
    • Rodríguez‐Romanos, Rocío;
    • Coll, Rosa;
    • Osca, Gemma;
    • Pratcorona, Marta;
    • González‐Bártulos, Marta;
    • Garrido, Ana;
    • Angona, Anna;
    • Talarn, Carme;
    • Tormo, Mar;
    • Arnan, Montserrat;
    • Vives, Susanna;
    • Salamero, Olga;
    • Tuset, Esperanza;
    • Lloveras, Natàlia;
    • Díez, Isabel;
    • Zamora, Lurdes;
    • Bargay, Joan;
    • Sampol, Antonia;
    • Cruz, David
    Publication type:
    Article
    47

    Busulfan‐based myeloablative conditioning regimens for haploidentical transplantation in high‐risk acute leukemias and myelodysplastic syndromes.

    Published in:
    European Journal of Haematology, 2018, v. 101, n. 3, p. 332, doi. 10.1111/ejh.13103
    By:
    • Gayoso, Jorge;
    • Balsalobre, Pascual;
    • Kwon, Mi;
    • Herrera, Pilar;
    • Bermúdez, Arancha;
    • Sampol, Antonia;
    • Jiménez, Santiago;
    • López‐Corral, Lucía;
    • Serrano, David;
    • Piñana, Jose Luis;
    • Pascual, María J.;
    • Heras, Inmaculada;
    • Bento, Leyre;
    • Varela, Rosario;
    • Humala, Karem;
    • Zabalza, Amaya;
    • Laiglesia, Almudena;
    • Bastos‐Oreiro, Mariana;
    • Pérez‐Corral, Ana;
    • Martínez‐Laperche, Carolina
    Publication type:
    Article